“I’maperfectexampleofearlyscreeningfor lungcancerandthegooditcando.Thecancer wasthereandIwouldneverhaveknown.” ~PegVernon,whoselungcancerscreeningtestdetected acanceroustumorbeforeitcouldgrowintoalife-threateningdisease. C O N C O R D H O S P I T A L A N N U A L R E P O R T 2 0 1 7 33 The low-dose beams meet at the tumor, providing a concentrated higher dose to the target. Meanwhile, while on the way to the tumor, the lower dose beams do not affect the rest of the brain and its function. Radiation oncologist Dr. Su Metcalfe said that in the past, patients whose cancer had spread to the brain would undergo two- to-three weeks of whole brain radiation. The treatment could prompt short-term memory loss, permanent hair loss and change some patients’quality of life. SRS radiation treatment can prevent tumors from growing, with fewer side effects. Most patients don’t lose hair. Payson Center added the SRS technology in 2017 after patients and healthcare providers in the community asked for it. Patients, many in a weakened state because of the spread of their cancer, reported it was a hardship to travel elsewhere for the SRS treatment. In the future, Payson Center may use SRS technology to treat other cancers of the liver and adrenal and pancreatic systems. LungCancerScreening Early detection is crucial to treating lung cancer.That is why Concord Hospital launched the Lung Cancer Screening program, a collaboration including Concord Hospital Medical Group (CHMG) primary and specialty care, New Hampshire Oncology-Hematology, Concord Imaging Center and Radiation Oncology Associates. The Lung Cancer Screening program includes low-dose computed tomography (LDCT) screening, in which an X-ray machine uses low doses of radiation to make detailed pictures of the lungs. LDCT is the only recommended screening test for early detection of lung cancer. Screenings can be performed at Concord Hospital or any Concord Imaging Center location. LDCT screening is recommended for currentorformersmokersages55to77 who have no symptoms of lung cancer and who meet the following criteria: § Individuals with a history of at least 30 pack years of smoking. (A‘pack year’ is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years of smoking); § Current or former smokers who have quit within the past 15 years. From October 1, 2016 through September 14, 2017, 702 patients received LDCT, which identified 14 lung cancers and 115 patients who needed further testing. “I’maperfectexampleofearlyscreeningfor lungcancerandthegooditcando.Thecancer wasthereandIwouldneverhaveknown.” ~PegVernon,whoselungcancerscreeningtestdetected acanceroustumorbeforeitcouldgrowintoalife-threateningdisease.